SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 305 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19 | -34.5% | 160 | -37.3% | 0.01% | -36.4% |
| Q2 2023 | $29 | -17.1% | 255 | 0.0% | 0.01% | -15.4% |
| Q1 2023 | $35 | +6.1% | 255 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $33 | -99.9% | 255 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $28,000 | +47.4% | 255 | 0.0% | 0.01% | +62.5% |
| Q2 2022 | $19,000 | -5.0% | 255 | 0.0% | 0.01% | +14.3% |
| Q1 2022 | $20,000 | -42.9% | 255 | -33.8% | 0.01% | -41.7% |
| Q4 2021 | $35,000 | -7.9% | 385 | -7.2% | 0.01% | -20.0% |
| Q3 2021 | $38,000 | +22.6% | 415 | +5.1% | 0.02% | +25.0% |
| Q2 2021 | $31,000 | -71.0% | 395 | -72.6% | 0.01% | -77.8% |
| Q1 2021 | $107,000 | +5.9% | 1,440 | +144.1% | 0.05% | 0.0% |
| Q4 2020 | $101,000 | +14.8% | 590 | -5.6% | 0.05% | +3.8% |
| Q3 2020 | $88,000 | -3.3% | 625 | +10.6% | 0.05% | -13.3% |
| Q2 2020 | $91,000 | +9.6% | 565 | -33.5% | 0.06% | -18.9% |
| Q1 2020 | $83,000 | +80.4% | 850 | +136.1% | 0.07% | +117.6% |
| Q4 2019 | $46,000 | +31.4% | 360 | -22.6% | 0.03% | +25.9% |
| Q3 2019 | $35,000 | -40.7% | 465 | +20.8% | 0.03% | -42.6% |
| Q2 2019 | $59,000 | +7.3% | 385 | -16.3% | 0.05% | 0.0% |
| Q1 2019 | $55,000 | – | 460 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |